SIC
SJS Investment Consulting’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3
| Closed | -$554 | – | 1620 |
|
|
2024
Q4 | $554 | Sell |
3
-6
| -67% | -$1.11K | ﹤0.01% | 1206 |
|
|
2024
Q3 | $1.77K | Buy |
9
+1
| +13% | +$197 | ﹤0.01% | 845 |
|
|
2024
Q2 | $1.65K | Hold |
8
| – | – | ﹤0.01% | 818 |
|
|
2024
Q1 | $2.17K | Buy |
8
+5
| +167% | +$1.36K | ﹤0.01% | 708 |
|
|
2023
Q4 | $710 | Sell |
3
-5
| -63% | -$1.18K | ﹤0.01% | 1100 |
|
|
2023
Q3 | $1.57K | Buy |
8
+3
| +60% | +$588 | ﹤0.01% | 740 |
|
|
2023
Q2 | $1.05K | Sell |
5
-1
| -17% | -$210 | ﹤0.01% | 886 |
|
|
2023
Q1 | $1.21K | Hold |
6
| – | – | ﹤0.01% | 810 |
|
|
2022
Q4 | $1.31K | Buy |
6
+3
| +100% | +$653 | ﹤0.01% | 821 |
|
|
2022
Q3 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 668 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 821 |
|